Naver on Wednesday launched a beta version of its generative AI search engine “Cue:,” a service similar to Microsoft’s Bing.
LG Chem's cancer immunotherapy candidate, CUE-102, won approval to start Phase 1 clinical trials from the U.S. Food and Drug Administration (FDA).
Korea JoongAng Daily Sitemap
